Cargando…

Peripheral glucocorticoid receptor antagonism by relacorilant with modest HPA axis disinhibition

Glucocorticoid stress hormones are produced in response to hypothalamic–pituitary–adrenal (HPA) axis activation. Glucocorticoids are essential for physiology and exert numerous actions via binding to the glucocorticoid receptor (GR). Relacorilant is a highly selective GR antagonist currently undergo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Viho, Eva M G, Kroon, Jan, Feelders, Richard A, Houtman, René, van den Dungen, Elisabeth S R, Pereira, Alberto M, Hunt, Hazel J, Hofland, Leo J, Meijer, Onno C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874980/ https://www.ncbi.nlm.nih.gov/pubmed/36445262 http://dx.doi.org/10.1530/JOE-22-0263

Ejemplares similares

What’s new on the HPA axis?
por: Hofland, Johannes, et al.
Publicado: (2015)

The selective glucocorticoid receptor antagonist CORT125281 has tissue-specific activity
por: Koorneef, Lisa L, et al.
Publicado: (2020)

THU035 Impact Of Surgery Or Medical Treatment With The Selective Glucocorticoid Receptor Modulator Relacorilant On Hypercoagulopathy In Patients With Cushing Syndrome
por: Simeoli, Chiara, et al.
Publicado: (2023)

Glucocorticoid Receptor Antagonism Upregulates Somatostatin Receptor Subtype 2 Expression in ACTH-Producing Neuroendocrine Tumors: New Insight Based on the Selective Glucocorticoid Receptor Modulator Relacorilant
por: Pivonello, Rosario, et al.
Publicado: (2022)

The Hippocampal Response to Acute Corticosterone Elevation Is Altered in a Mouse Model for Angelman Syndrome
por: Viho, Eva M. G., et al.
Publicado: (2022)

An In Vitro and In Vivo Evaluation of the Effect of Relacorilant on the Activity of Cytochrome P450 Drug Metabolizing Enzymes
por: Custodio, Joseph M., et al.
Publicado: (2020)

Glucocorticoid receptor antagonism promotes apoptosis in solid tumor cells
por: Greenstein, Andrew E., et al.
Publicado: (2021)

Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study
por: Pivonello, Rosario, et al.
Publicado: (2021)

The HPA – Immune Axis and the Immunomodulatory Actions of Glucocorticoids in the Brain
por: Bellavance, Marc-André, et al.
Publicado: (2014)

Stress and the HPA Axis: Role of Glucocorticoids in Alcohol Dependence
por: Stephens, Mary Ann C., et al.
Publicado: (2012)

Cell type specificity of glucocorticoid signaling in the adult mouse hippocampus
por: Viho, Eva M. G., et al.
Publicado: (2021)

Corrigendum: Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study
por: Pivonello, Rosario, et al.
Publicado: (2022)

Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer
por: Kroon, Jan, et al.
Publicado: (2016)

Role of glucocorticoid negative feedback in the regulation of HPA axis pulsatility
por: Gjerstad, Julia K, et al.
Publicado: (2018)

A Model of Glucocorticoid Receptor Interaction With Coregulators Predicts Transcriptional Regulation of Target Genes
por: Monczor, Federico, et al.
Publicado: (2019)

Overcoming Taxane Resistance: Preclinical and Phase 1 Studies of Relacorilant, a Selective Glucocorticoid Receptor Modulator, with Nab-Paclitaxel in Solid Tumors
por: Munster, Pamela N., et al.
Publicado: (2022)

PMON165 Favorable Liver Safety Profile of the Selective Glucocorticoid Receptor Modulator Relacorilant in Healthy and Hepatically Impaired Adults and in Patients with Cushing Syndrome
por: Moraitis, Andreas, et al.
Publicado: (2022)

The Different Roles of Glucocorticoids in the Hippocampus and Hypothalamus in Chronic Stress-Induced HPA Axis Hyperactivity
por: Zhu, Li-Juan, et al.
Publicado: (2014)

SUN-207 Modelling Long Term Glucocorticoid-Induced HPA Axis Suppression in Mice
por: Romano, Nicola, et al.
Publicado: (2020)

Relacorilant With Pembrolizumab: A Phase 1b, Open-Label Study of a Selective Glucocorticoid Receptor Modulator Combined With a Checkpoint Inhibitor for Patients With Adrenocortical Carcinoma With Excess Glucocorticoid Production
por: Habra, Mouhammed Amir, et al.
Publicado: (2021)

Biphasic Glucocorticoid Rhythm in One-Month-Old Infants: Reflection of a Developing HPA-Axis?
por: Hollanders, Jonneke J, et al.
Publicado: (2019)

OR19-04 Glucocorticoid Production in the Nervous and Immune Systems: Evidence for a Local HPA Axis Homolog
por: Salehzadeh, Melody, et al.
Publicado: (2020)

Prenatal stress modulates HPA axis homeostasis of offspring through dentate TERT independently of glucocorticoids receptor
por: Liu, Meng-Ying, et al.
Publicado: (2022)

Antioxidant Treatment Induces Hyperactivation of the HPA Axis by Upregulating ACTH Receptor in the Adrenal and Downregulating Glucocorticoid Receptors in the Pituitary
por: Prevatto, Jessika P., et al.
Publicado: (2017)

Is PTSD-Phenotype Associated with HPA-Axis Sensitivity? Feedback Inhibition and Other Modulating Factors of Glucocorticoid Signaling Dynamics
por: Danan, Dor, et al.
Publicado: (2021)

Maternal precarity and HPA axis functioning shape infant gut microbiota and HPA axis development in humans
por: Jahnke, Johanna R., et al.
Publicado: (2021)

SUN-451 A Randomized-Withdrawal, Placebo-Controlled, Phase 3 Study to Assess the Efficacy and Safety of Selective Glucocorticoid Receptor Antagonist, Relacorilant, in Patients with Cushing Syndrome (GRACE Study)
por: Auchus, Richard, et al.
Publicado: (2019)

Telencephalic regulation of the HPA axis in birds
por: Smulders, Tom V.
Publicado: (2021)

SUN-463 Tumor Shrinkage with Preoperative Relacorilant Therapy in Two Patients with Cushing Disease Due to Pituitary Macroadenomas
por: Terzolo, Massimo, et al.
Publicado: (2019)

Do Corticosteroid Receptor mRNA Levels Predict the Expression of Their Target Genes?
por: Koorneef, Lisa L, et al.
Publicado: (2022)

Exposure to the Indian Ocean Tsunami shapes the HPA-axis resulting in HPA “burnout” 14 years later
por: Lawton, Ralph, et al.
Publicado: (2023)

Hippocampal glucocorticoid target genes associated with enhancement of memory consolidation
por: Buurstede, Jacobus C., et al.
Publicado: (2021)

GLUCOCORTICOID-INDUCED HYPERTENSION AND CARDIAC INJURY: EFFECTS OF MINERALOCORTICOID AND GLUCOCORTICOID RECEPTOR ANTAGONISM
por: HATTORI, TAKUYA, et al.
Publicado: (2013)

Effects of persistent environmental pollutants on the HPA-axis
por: Zimmer, Karin
Publicado: (2012)

Stress and the HPA Axis: Balancing Homeostasis and Fertility
por: Joseph, Dana N., et al.
Publicado: (2017)

Immune Modulations by Glucocorticoids: From Molecular Biology to Clinical Research
por: J. M. Schaaf, Marcel, et al.
Publicado: (2022)

Disinhibition Bursting of Dopaminergic Neurons
por: Lobb, Collin J., et al.
Publicado: (2011)

Saccadic Disinhibition on the Saccade Trace
por: Yan, Hongmei, et al.
Publicado: (2011)

The caffeine-binding adenosine A(2A) receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function
por: Batalha, Vânia L., et al.
Publicado: (2016)

In Search of HPA Axis Dysregulation in Child and Adolescent Depression
por: Guerry, John D., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_rbl115avbbtgmj7ocq3ac2vf9d